Our study focuses on a child with a recombination-activating gene 1 (RAG1) deficiency who was identified through a screening program for Slavic founder genetic variants among patients who died with malignancy at an early age in Belarus. This evidence concerns the gene RAG1 and hyperinsulinemic hypoglycemia, familial, 4.